[Federal Register Volume 69, Number 106 (Wednesday, June 2, 2004)]
[Notices]
[Pages 31099-31100]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-12419]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[OPPT-2004-0084; FRL-7361-4]


Establishment of the Endocrine Disruptor Methods Validation 
Advisory Committee

AGENCY: Environmental Protection Agency (EPA).

ACTION: Establishment of Federal Advisory Committee Act Committee.

-----------------------------------------------------------------------

SUMMARY: As required by section 9(a)(2) of the Federal Advisory 
Committee Act (5 U.S.C. App. 2 section 9(a)(2)), we are giving notice 
that EPA is establishing the Endocrine Disruptor Methods Validation 
Advisory Committee (EDMVAC). The purpose of this Committee is to 
provide a forum for a diverse group of individuals representing a broad 
range of interests and scientific expertise. It will provide advice to 
the Agency on matters related to the validation of assays under 
consideration by the Endocrine Disruptor Screening Program (EDSP). The 
Committee will analyze relevant scientific issues, protocols, review 
data and interpretations of data for the assays. The major objective of 
the Committee is to provide advice and recommendations to the EPA 
Administrator on scientific and technical aspects of the assays as they 
progress through the validation process. EPA has determined that this 
advisory committee is in the public interest and will assist the Agency 
in performing its duties as prescribed by the Food Quality Protection 
Act of 1996. Copies of the Committee Charter will be filed with the 
appropriate congressional committees and the Library of Congress.

FOR FURTHER INFORMATION CONTACT:
    For general information contact: Colby Lintner, Regulatory 
Coordinator, Environmental Assistance Division (7404M), Office of 
Pollution Prevention and Toxics, Environmental Protection Agency, 1200 
Pennsylvania Ave., NW., Washington, DC 20460; telephone number: (202) 
564-1404; e-mail address: [email protected].
    For technical information contact: Jane Smith, Designated Federal 
Official, Office of Science Coordination and Policy (7201M), 
Environmental Protection Agency, 1200 Pennsylvania Ave., NW., 
Washington, DC 20460; telephone number: (202) 564-8476, fax: (202) 564-
8283; e-mail address: [email protected].

SUPPLEMENTARY INFORMATION:

I. Does this Action Apply to Me?

    This action is directed to the public in general. You may be 
interested in the establishment of the committee set forth in this 
notice if you are a member of an environmental/public interest 
organization, a public health organization, an animal welfare 
organization, academia or Federal agencies, state, local, or tribal 
governments. You also may be interested in activities of EPA's EDSP if 
you produce, manufacture, use, consume, work with, or import pesticides 
or other chemicals. Since other entities may also be interested, the 
Agency has not attempted to describe all the specific entities that may 
be affected by this action. If you have any questions regarding this 
action, please contact the technical person listed under FOR FURTHER 
INFORMATION CONTACT.

[[Page 31100]]

II. How Can I Get Additional Information, Including Copies of this 
Document or Other Related Documents?

    1. Electronically. You may access this Federal Register document 
electronically through the EPA Internet site under the ``Federal 
Register'' listings at http://www.epa.gov/fedrgstr/.
    Information about the former Endocrine Disruptor Methods Validation 
Subcommittee, the Endocrine Disruptor Screening Program and related 
programs is available from http://www.epa.gov/scipoly/oscpendo/.
    EPA has established an official public docket for the EDMVAC under 
docket identification (ID) number OPPT-2004-0084. The official public 
docket consists of the documents related to the activities of the 
committee and any public comments received. Although a part of the 
official docket, the public docket does not include Confidential 
Business Information (CBI) or other information whose disclosure is 
restricted by statute.
    An electronic version of the public docket is available through 
EPA's electronic public docket and comment system, EPA Dockets. You may 
use EPA Dockets at http://www.epa.gov/edocket/ to access the index 
listing of the contents of the official public docket, and to access 
those documents in the public docket that are available electronically. 
Although not all docket materials may be available electronically, you 
may still access any of the publicly available docket materials through 
the docket facility identified in Unit II.2. Once in the system, select 
``search,'' then key in the appropriate docket ID number.
    2. In person. The official public docket is the collection of 
materials that is available for public viewing at the EPA Docket 
Center, Rm. B102-Reading Room, EPA West, 1301 Constitution Ave., NW., 
Washington, DC. The EPA Docket Center is open from 8:30 a.m. to 4:30 
p.m., Monday through Friday, excluding legal holidays. The EPA Docket 
Center Reading Room telephone number is (202) 566-1744 and the 
telephone number for the OPPT Docket, which is located in the EPA 
Docket Center, is (202) 566-0272.
    3. By mail. You may obtain copies of this document and other 
related documents from the technical contact person listed under FOR 
FURTHER INFORMATION CONTACT.

List of Subjects

    Environmental protection, Endocrine disruptors, Endocrine Disruptor 
Screening Program, Endocrine Disrupor Methods Validation Advisory 
Committee.


    Dated: May 18, 2004.
Susan B. Hazen,
Assistant Administrator, Office of Prevention, Pesticides and Toxic 
Substances.

[FR Doc. 04-12419 Filed 6-1-04; 8:45 am]
BILLING CODE 6560-50-S